Literature DB >> 30649775

Clinical and Functional Evaluation of Ocular Inflammatory Disease Using the Model of Experimental Autoimmune Uveitis.

Jun Chen1,2, Rachel R Caspi3.   

Abstract

Non-infections uveitis in humans is an autoimmune disease of the retina and uvea that can be blinding if untreated. Its laboratory equivalent is experimental autoimmune uveitis (EAU) induced in susceptible rodents by immunization with retinal antigens and described elsewhere in this series (Agarwal et al., Methods Mol Biol, 900:443-469, 2012). Evaluation and quantitation of the disease is usually performed by fundus examination and/or histopathology, which provide limited information on structural and no information on functional changes as disease progresses. Here, we describe methods for systematic evaluation of disease using noninvasive clinical assessments by fundus examination and photography, optical coherence tomography, and functional evaluation by electroretinography, which are then compared to histopathology. Using these methodologies, we demonstrate that clinical variants of disease can be accurately evaluated both clinically and functionally, facilitating longitudinal follow-up and providing information that cannot be obtained by fundoscopy and histology alone. These methodologies can be useful to obtain additional information and to evaluate effects of therapeutic modalities under investigation.

Entities:  

Keywords:  Autoimmunity; EAU; Electroretinography; Fundoscopy; Histology; IRBP; Mouse; Optical coherence tomography; S-Ag; T cells; Tolerance; Uveitis

Mesh:

Substances:

Year:  2019        PMID: 30649775      PMCID: PMC6754184          DOI: 10.1007/978-1-4939-8938-6_15

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  9 in total

1.  Therapeutic Validation of GEF-H1 Using a De Novo Designed Inhibitor in Models of Retinal Disease.

Authors:  Clare Mills; Sandra A Hemkemeyer; Zerin Alimajstorovic; Chantelle Bowers; Malihe Eskandarpour; John Greenwood; Virginia Calder; A W Edith Chan; Paul J Gane; David L Selwood; Karl Matter; Maria S Balda
Journal:  Cells       Date:  2022-05-24       Impact factor: 7.666

Review 2.  The Gut-Eye Axis: Lessons Learned from Murine Models.

Authors:  Jason L Floyd; Maria B Grant
Journal:  Ophthalmol Ther       Date:  2020-07-02

3.  Apremilast Regulates the Teff/Treg Balance to Ameliorate Uveitis via PI3K/AKT/FoxO1 Signaling Pathway.

Authors:  Yuxi Chen; Zhuang Li; He Li; Wenru Su; Yanyan Xie; Yuan Pan; Xiaoqing Chen; Dan Liang
Journal:  Front Immunol       Date:  2020-11-17       Impact factor: 7.561

4.  Therapeutic Effect of IL-38 on Experimental Autoimmune Uveitis: Reprogrammed Immune Cell Landscape and Reduced Th17 Cell Pathogenicity.

Authors:  He Li; Lei Zhu; Rong Wang; Lihui Xie; Yuxi Chen; Runping Duan; Xiuxing Liu; Zhaohao Huang; Binyao Chen; Zhaohuai Li; Xianggui Wang; Wenru Su
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-12-01       Impact factor: 4.799

5.  Prednisone Reprograms the Transcriptional Immune Cell Landscape in CNS Autoimmune Disease.

Authors:  He Li; Yuehan Gao; Lihui Xie; Rong Wang; Runping Duan; Zhaohuai Li; Binyao Chen; Lei Zhu; Xianggui Wang; Wenru Su
Journal:  Front Immunol       Date:  2021-08-13       Impact factor: 7.561

Review 6.  The Role of Retinal Pigment Epithelial Cells in Regulation of Macrophages/Microglial Cells in Retinal Immunobiology.

Authors:  Andrew W Taylor; Samuel Hsu; Tat Fong Ng
Journal:  Front Immunol       Date:  2021-08-13       Impact factor: 7.561

7.  Aging weakens Th17 cell pathogenicity and ameliorates experimental autoimmune uveitis in mice.

Authors:  He Li; Lei Zhu; Rong Wang; Lihui Xie; Jie Ren; Shuai Ma; Weiqi Zhang; Xiuxing Liu; Zhaohao Huang; Binyao Chen; Zhaohuai Li; Huyi Feng; Guang-Hui Liu; Si Wang; Jing Qu; Wenru Su
Journal:  Protein Cell       Date:  2021-11-08       Impact factor: 15.328

8.  Apolipoprotein A1 Modulates Teff/Treg Balance Through Scavenger Receptor Class B Type I-Dependent Mechanisms in Experimental Autoimmune Uveitis.

Authors:  Haixiang Huang; Zhuang Li; Jun Huang; Yanyan Xie; Zhiqiang Xiao; Yunwei Hu; Guanyu Chen; Minzhen Wang; Zuoyi Li; Qian Chen; Wenjie Zhu; Wenru Su; Yan Luo; Xiaoqing Chen; Dan Liang
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-07-08       Impact factor: 4.925

Review 9.  Quantitative Assessment of Experimental Ocular Inflammatory Disease.

Authors:  Lydia J Bradley; Amy Ward; Madeleine C Y Hsue; Jian Liu; David A Copland; Andrew D Dick; Lindsay B Nicholson
Journal:  Front Immunol       Date:  2021-06-18       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.